CLINICAL_TRIALS
trial_result
· 2020-11-02
Clinical Trial Update: A Multicenter Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADH [Phase 3]
Summary
Phase 3 multicenter trial evaluating tolvaptan for hyponatremia due to SIADH; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Syndrome of Inappropriate Antidiuretic Hormone Secretion | Phase 3 | Status: COMPLETED | Results posted: 2020-11-02